GRK2 expression levels appear to determine the beneficial outcome of AAV9-mediated βARKct gene therapy in different mouse models of inherited cardiomyopathy
Publication
, Conference
Bauer, R; Enns, H; Jungmann, A; Leuchs, B; Volz, C; Schinkel, S; Koch, WJ; Raake, PW; Most, P; Katus, HA; Mueller, OJ
Published in: HUMAN GENE THERAPY
2015
Duke Scholars
Published In
HUMAN GENE THERAPY
EISSN
1557-7422
ISSN
1043-0342
Publication Date
2015
Volume
26
Issue
10
Start / End Page
A4 / A5
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 1103 Clinical Sciences
- 1004 Medical Biotechnology
Citation
APA
Chicago
ICMJE
MLA
NLM
Bauer, R., Enns, H., Jungmann, A., Leuchs, B., Volz, C., Schinkel, S., … Mueller, O. J. (2015). GRK2 expression levels appear to determine the beneficial outcome of AAV9-mediated βARKct gene therapy in different mouse models of inherited cardiomyopathy. In HUMAN GENE THERAPY (Vol. 26, pp. A4–A5).
Bauer, R., H. Enns, A. Jungmann, B. Leuchs, C. Volz, S. Schinkel, W. J. Koch, et al. “GRK2 expression levels appear to determine the beneficial outcome of AAV9-mediated βARKct gene therapy in different mouse models of inherited cardiomyopathy.” In HUMAN GENE THERAPY, 26:A4–5, 2015.
Bauer R, Enns H, Jungmann A, Leuchs B, Volz C, Schinkel S, et al. GRK2 expression levels appear to determine the beneficial outcome of AAV9-mediated βARKct gene therapy in different mouse models of inherited cardiomyopathy. In: HUMAN GENE THERAPY. 2015. p. A4–5.
Bauer, R., et al. “GRK2 expression levels appear to determine the beneficial outcome of AAV9-mediated βARKct gene therapy in different mouse models of inherited cardiomyopathy.” HUMAN GENE THERAPY, vol. 26, no. 10, 2015, pp. A4–5.
Bauer R, Enns H, Jungmann A, Leuchs B, Volz C, Schinkel S, Koch WJ, Raake PW, Most P, Katus HA, Mueller OJ. GRK2 expression levels appear to determine the beneficial outcome of AAV9-mediated βARKct gene therapy in different mouse models of inherited cardiomyopathy. HUMAN GENE THERAPY. 2015. p. A4–A5.
Published In
HUMAN GENE THERAPY
EISSN
1557-7422
ISSN
1043-0342
Publication Date
2015
Volume
26
Issue
10
Start / End Page
A4 / A5
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 1103 Clinical Sciences
- 1004 Medical Biotechnology